FDA PMA Submission Consulting for Medical Devices
Navigate the complexities of FDA Premarket Approval (PMA) submissions with expert guidance to ensure the safety, effectiveness, and successful market entry of your medical devices.
Understanding the FDA Premarket Approval (PMA) Process
While most medical devices and IVDs must submit a 510(k) for US FDA clearance, many high-risk and novel Class III devices require a more rigorous regulatory route known as Premarket Approval (PMA). The PMA submission is a dossier of scientific information about your device that demonstrates it is safe and effective for its intended use. The PMA route is a lengthy process that requires clinical investigations and precise scientific writing.
Who must submit an FDA PMA?
The majority of FDA submissions leverage substantial equivalence to demonstrate the safety and effectiveness of a device. However, many high-risk devices do not have a substantially equivalent predicate device on the market. Novel devices may petition the FDA for reclassification to Class I or II if they can provide adequate data to demonstrate a lower risk profile. Otherwise, novel devices are ruled a Class III, which requires a PMA. Devices that may have a predicate but are very high risk because they are life-supporting, sustaining and or carry a high risk-to-benefit ratio are ruled a Class III. While not required, a Pre-submission (or Q-sub) meeting with the FDA is advisable to ensure PMA is the best path for your device.
What is required for an FDA PMA?
The list of required information for PMA is extensive. It is critical to address each requirement to ensure your application moves through the administrative review. PMAs share many requirements of the 510(k), but there is a heavy emphasis on non-clinical and clinical data, as well as clinical investigations. The FDA will look closely at your non-clinical laboratory studies and clinical investigations, how they were conducted, and the consistency of the data presented. The effectiveness of your PMA hinges on study design and data quality.
PMA requires a lot of resources and a deep understanding of FDA expectations, but it’s worth it to bring devices to market that elevate the standard of care. MedEnvoy’s team of experienced consultants has decades of experience preparing PMA submissions and working with manufacturers of high-risk devices. We know what FDA reviewers are looking for.
How we can help:
Regulatory strategy development
We work closely with you to develop a tailored regulatory strategy and ensure PMA is an appropriate pathway for your device.
FDA interaction and communication
We facilitate early collaboration with the FDA, representing your interests and ensuring any pre-submission meetings produce clear objectives.
Documentation review and compilation
Our experienced team meticulously reviews and compiles all necessary documentation, including clinical trial data, risk assessments, and quality control measures, to create a comprehensive PMA submission package.
Quality system implementation
We assist in implementing and enhancing quality systems within your organization to meet FDA requirements.
Clinical trial support
Our experts provide guidance on designing and conducting clinical trials that generate the necessary data to support the safety and effectiveness of your medical device.
Post-approval support
Our commitment extends beyond approval. We provide ongoing support to address any post-approval requirements and maintain compliance throughout the product life cycle.
